Cannonau Corp. (CNNC) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - Specialty & Generic industria. La empresa tiene su sede en Skaneateles, NY, United States. El CEO actual es Markwin Maring.
CNNC tiene fecha de IPO 2010-03-12, 4 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $48.28K.
Cannonau Corp. engages in developing cannabidiol based products. The company was formerly known as Pacific Blue Energy Corp. and changed its name to Cannonau Corp. in August 2019. Cannonau Corp. was incorporated in 2007 and is based in Skaneateles, New York.
